Nimrata Hunt - 03 Mar 2026 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Reporting relationship: Executive Vice President
Issuer ticker: IDXX
Reported as of: 03 Mar 2026
Net transaction value: -$1,115,577
SEC form: 4
Accepted by SEC: 05 Mar 2026, 17:01:28 UTC
Prior SEC filing: 27 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Lily J. Lu, Attorney-in-Fact for Nimrata Hunt

Key filing fact

Nimrata Hunt filed Form 4 for IDEXX LABORATORIES INC /DE (IDXX) on 05 Mar 2026.

Key facts

This page summarizes Nimrata Hunt's Form 4 filing for IDEXX LABORATORIES INC /DE (IDXX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 05 Mar 2026, 17:01.

Change

Previous filing in this sequence was filed on 27 Feb 2026.
Current net transaction value: -$1,115,577.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001800619 Primary reporting owner

Hunt Nimrata

Relationship: Executive Vice President
Address: ONE IDEXX DRIVE, WESTBROOK
Signature: /s/ Lily J. Lu, Attorney-in-Fact for Nimrata Hunt
Signature date: 05 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IDXX transaction

Common Stock

Sale

Transaction value: $1,115,577
Shares: -1,758
Change %: -8.8%
Price: $634.57
Shares after: 18,141
Date: 03 Mar 2026
Ownership: Direct
Footnotes: F1

IDXX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 160
Date: 03 Mar 2026
Ownership: jointly with spouse

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents the weighted average price of the shares sold ranging from a low of $634.5301 to a high of $634.8201 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.